Kevin P. Rosenbach

Allergy and Immunology

2500 Vanderbilt Beach Rd Ste 1103
Naples, FL 34109

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

Real-world retrospective cohort study evaluating the tolerability of immune globulin intravenous 10% (BIVIGAM®).

Real-world retrospective cohort study evaluating the tolerability of immune globulin intravenous 10% (BIVIGAM®).

Journal: Frontiers in immunology

Published: August 17, 2025

ASCENIV utilization in a primary immunodeficiency patient with recurrent viral infections.

ASCENIV utilization in a primary immunodeficiency patient with recurrent viral infections.

Journal: Immunological medicine

Published: December 23, 2022

Real-World Evidence of Tolerability of 20% Subcutaneous Immunoglobulin Treatment.

Real-World Evidence of Tolerability of 20% Subcutaneous Immunoglobulin Treatment.

Journal: Journal of clinical immunology

Published: May 27, 2022

Showing 1-3 of 3

Last Updated: 09/26/2026